Acutus Medical Inc (NASDAQ: AFIB) stock jumped 39.67% on Monday to $0.34 against a previous-day closing price of $0.25. With 7.14 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.35 million shares. During the session, the Medical Devices company that operates in wider Healthcare sector, reached to the highest price of $0.4190 whereas the lowest price it dropped to was $0.2310. The 52-week range on AFIB shows that it touched its highest point at $1.96 and its lowest point at $0.16 during that stretch. It currently has a 1-year price target of $0.50. Beta for the stock currently stands at 0.26.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of AFIB was up-trending over the past week, with a rise of 72.14%, but this was down by -40.76% over a month. Three-month performance dropped to -33.02% while six-month performance fell -64.58%. The stock lost -44.76% in the past year, while it has lost -70.12% so far this year. A look at the trailing 12-month EPS for AFIB yields -1.25 with Next year EPS estimates of -1.56. For the next quarter, that number is -0.39. This implies an EPS growth rate of 27.06% for this year and 34.60% for next year.
Float and Shares Shorts:
At present, 28.55 million AFIB shares are outstanding with a float of 18.50 million shares on hand for trading. On Oct 30, 2023, short shares totaled 0.25 million, which was 0.86% higher than short shares on Sep 28, 2023. In addition to Mr. R. Scott Huennekens CPA, M.B.A. as the firm’s Executive Chairman, Mr. David Harrison Roman serves as its CEO, President & Director.
Through their ownership of 37.45% of AFIB’s outstanding shares, institutional investors have minority control over the company.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for AFIB since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With AFIB analysts setting a high price target of $0.50 and a low target of $0.50, the average target price over the next 12 months is $0.50. Based on these targets, AFIB could surge 47.06% to reach the target high and rise by 47.06% to reach the target low. Reaching the average price target will result in a growth of 47.06% from current levels.
Summary of Insider Activity:
Insiders traded AFIB stock several times over the past three months with 0 Buys and 1 Sells. In these transactions, 0 shares were bought while 1,729 shares were sold. The number of buy transactions has increased to 15 while that of sell transactions has risen to 15 over the past year. The total number of shares bought during that period was 408,120 while 61,510 shares were sold.